Adagio Medical Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adagio Medical Holdings, Inc. (ADGM) on June 12, 2026. The Company is an emerging growth company incorporated in Delaware, with its common stock listed on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a regulatory compliance matter regarding the Company's stock price.
Material Changes and Events
On June 12, 2026, the Company received a notice from Nasdaq stating that its common stock failed to comply with Listing Rule 5550(a)(2) due to the minimum bid price falling below $1.00 per share for 30 consecutive business days. This notice does not immediately impact the listing status.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has 180 calendar days, until December 9, 2026, to regain compliance.
- Compliance Criteria: Compliance is achieved if the bid price closes at or above $1.00 per share for ten consecutive trading days before the deadline.
- Contingencies: If the Company fails to regain compliance by December 9, 2026, it may be eligible for a second 180-day period if it notifies Nasdaq of its intent to comply, potentially via a reverse stock split, and meets other listing standards.
- Risks: There is no assurance the Company will regain compliance. Failure to qualify for a second period or to comply during that period will result in delisting.
Investor Verification Checklist
- Verify the current trading price of ADGM common stock relative to the $1.00 threshold.
- Monitor the Company's announcement regarding the potential implementation of a reverse stock split.
- Confirm the Company's status regarding the December 9, 2026, compliance deadline.
- Review subsequent filings for updates on the bid price or delisting notifications.